Viewing by:
The world has been waiting for the next scientific breakthrough in cryopreservation. Dimethyl sulfoxide (DMSO), a by-product of the wood industry, has been in use
X-Therma is proud to announce an important milestone on our journey toward enabling more and better organ transplants and off-the-shelf regenerative medicine therapies: Our company
I have spent my life thinking about time. How to pause it. How to create more of it. How to extend it, so that people
Arthi Shridhar of X-Therma provides valuable insight into fixing the regenerative medicine supply chain.
What a wonderful celebration of the 7th anniversary we had on Halloween weekend! We truly appreciate the commitment and contribution of our dedicated team and
Cryopreservation should maintain the function and viability of organs and cell therapies, but the process is riddled with challenges. Can nature-inspired proteins make a difference?
The organ transplantation field has experienced numerous barriers which have contributed to the creation of organ accessibility issues worldwide. To help tackle these challenges, X-Therma
The preservation of living cells and tissues is an often-underappreciated obstacle in the clinical lab. Cryogenic temperatures attempt to address this challenge by minimizing biochemical
While traditional biologics continue to see strong market demand, the need for emerging therapies, such as regenerative medicines, has also given rise to a burgeoning
X-Therma Inc., a biotechnology company developing breakthrough technology for regenerative medicine and organ preservation – announced today that The Center for Devices and Radiological Health (CDRH)
"*" indicates required fields
X-Therma, Inc.
2600 Hilltop Drive
Suite B220
Richmond, CA 94806
USA
Kaiserjägerstraße 30
6020 Innsbruck
Austria
2600 Hilltop Drive
Suite B220
Richmond, CA 94806
USA
Kaiserjägerstraße 30
6020 Innsbruck
Austria
